Published in Paediatr Child Health on April 01, 2007
Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA (1998) 15.66
Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis (2003) 13.83
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA (2003) 12.04
Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet (2002) 10.26
Community-acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis (2005) 6.85
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest (2003) 5.64
Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis (2005) 3.91
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) (2003) 3.66
Community-associated methicillin-resistant Staphylococcus aureus, Canada. Emerg Infect Dis (2005) 3.36
Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis (1999) 2.81
Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene (2001) 2.67
Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J (2002) 2.47
Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J (2003) 1.76
Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro. J Infect Dis (2004) 1.76
Community-based cluster of methicillin-resistant Staphylococcus aureus in Manitoba. Can J Infect Dis (2001) 1.43
Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis (2006) 1.33
Treatment of community-associated methicillin-resistant Staphylococcus aureus infections. Pediatr Infect Dis J (2005) 1.29
Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol (2005) 1.27
Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J (2005) 1.27
Intravenous immunoglobulin therapy for toxic shock syndrome. JAMA (1992) 1.23
It's not a spider bite, it's community-acquired methicillin-resistant Staphylococcus aureus. J Am Board Fam Pract (2004) 1.12
Is methicillin-resistant Staphylococcus aureus an emerging community pathogen? A review of the literature. Can J Infect Dis (2000) 0.99
The emergence of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in Canada. Can J Infect Dis (2003) 0.94
Daptomycin: a cyclic lipopeptide antimicrobial agent. Clin Ther (2004) 0.90
Linezolid for the treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J (2003) 0.84
A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol (2007) 0.81
Regions of strong coupling between soil moisture and precipitation. Science (2004) 5.96
Challenges in end-of-life care in the ICU. Statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003. Intensive Care Med (2004) 3.16
Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ (2009) 3.11
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2009) 2.66
Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ (2004) 2.11
Healthcare-associated influenza in Canadian hospitals from 2006 to 2012. Infect Control Hosp Epidemiol (2014) 2.06
A 12-year prospective study of childhood herpes simplex encephalitis: is there a broader spectrum of disease? Pediatrics (2007) 2.03
Multiple mechanisms of Amazonian forest biomass losses in three dynamic global vegetation models under climate change. New Phytol (2010) 1.85
Stenotrophomonas maltophilia in cystic fibrosis: serologic response and effect on lung disease. Am J Respir Crit Care Med (2010) 1.82
Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners. Can J Infect Dis Med Microbiol (2006) 1.81
Estimating the risk of Amazonian forest dieback. New Phytol (2010) 1.50
Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med (2002) 1.46
Prednisolone and cefapirin act synergistically in resolving experimental Escherichia coli mastitis. J Dairy Sci (2013) 1.45
Pediatric Epstein-Barr Virus-Associated Encephalitis: 10-Year Review. J Child Neurol (2006) 1.41
Failure to prevent perinatal HIV infection. CMAJ (2002) 1.39
A national review of vertical HIV transmission. AIDS (2012) 1.38
Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis. Eur Respir J (2011) 1.31
Acute childhood encephalitis and encephalopathy associated with influenza: a prospective 11-year review. Pediatr Infect Dis J (2008) 1.28
Observing terrestrial ecosystems and the carbon cycle from space. Glob Chang Biol (2015) 1.26
Assessing uncertainties in a second-generation dynamic vegetation model caused by ecological scale limitations. New Phytol (2010) 1.24
The influence of terrestrial ecosystems on climate. Trends Ecol Evol (2006) 1.21
Tipping points in open systems: bifurcation, noise-induced and rate-dependent examples in the climate system. Philos Trans A Math Phys Eng Sci (2012) 1.20
Bacterial endocarditis in a child presenting with acute arterial ischemic stroke: should thrombolytic therapy be absolutely contraindicated? Dev Med Child Neurol (2009) 1.19
A child with raccoon roundworm meningoencephalitis: A pathogen emerging in your own backyard? Can J Infect Dis Med Microbiol (2009) 1.17
Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatr Pulmonol (2009) 1.09
Topsy-turvy heart with associated congenital tracheobronchial stenosis and airway compression requiring surgical reconstruction. Ann Thorac Surg (2008) 1.07
Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases. Antivir Ther (2010) 1.06
Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. PLoS One (2013) 1.05
HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era. Infect Dis Obstet Gynecol (2012) 1.05
Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus. J Pediatr (2011) 1.04
Novel mutations in a patient isolate of Streptococcus agalactiae with reduced penicillin susceptibility emerging after long-term oral suppressive therapy. Antimicrob Agents Chemother (2011) 1.02
Perinatal exposure to antiretroviral therapy is associated with increased blood mitochondrial DNA levels and decreased mitochondrial gene expression in infants. J Infect Dis (2008) 1.01
Pediatric Epstein-Barr virus-associated encephalitis: 10-year review. J Child Neurol (2006) 0.99
AMMI Canada position paper: 2012 Mandatory influenza immunization of health care workers. Can J Infect Dis Med Microbiol (2012) 0.98
Role of respiratory viruses in pulmonary exacerbations in children with cystic fibrosis. J Cyst Fibros (2012) 0.96
Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada. Antimicrob Agents Chemother (2012) 0.96
Chronic Stenotrophomonas maltophilia infection and exacerbation outcomes in cystic fibrosis. J Cyst Fibros (2011) 0.96
Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients. J Cyst Fibros (2013) 0.94
Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control (2012) 0.94
Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J Gene Med (2005) 0.93
Idiopathic suppurative pylephlebitis: interventional radiological diagnosis and management. Cardiovasc Intervent Radiol (2009) 0.93
Pneumococcal vaccination programs and the burden of invasive pneumococcal disease in Ontario, Canada, 1995-2011. Vaccine (2013) 0.91
Leukocyte telomere length in HIV-infected and HIV-exposed uninfected children: shorter telomeres with uncontrolled HIV viremia. PLoS One (2012) 0.90
Prevalence of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections in patients presenting to Canadian emergency departments. CJEM (2013) 0.89
Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD. Mol Pharmacol (2005) 0.89
Identification of zoonotic Cryptosporidium and Giardia genotypes infecting animals in Sydney's water catchments. Exp Parasitol (2011) 0.85
Necrotizing pneumonia complicated by early and late pneumatoceles. Can Respir J (2008) 0.85
Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae. PLoS One (2013) 0.85
Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons. Am J Infect Control (2013) 0.84
A retrospective cross-sectional study of risk factors and clinical spectrum of children admitted to hospital with pandemic H1N1 influenza as compared to influenza A. BMJ Open (2012) 0.83
A nosocomial outbreak of community-associated methicillin-resistant Staphylococcus aureus among healthy newborns and postpartum mothers. Can J Infect Dis Med Microbiol (2007) 0.81
Ethics: end-of-life decision-making in a pediatric patient with SMA type 2: the influence of the media. Neurology (2012) 0.81
Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit. Pediatr Crit Care Med (2013) 0.81
Invasive aspergillosis in cystic fibrosis: a fatal case in an adolescent and review of the literature. Pediatr Infect Dis J (2011) 0.81
Severe acute respiratory syndrome (SARS): chest radiographic features in children. Pediatr Radiol (2003) 0.81
Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients. J Antimicrob Chemother (2007) 0.80
Influenza-associated encephalopathy with elevated antibody titers to pandemic (H1N1) 2009 influenza. J Child Neurol (2011) 0.80
Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic. Antimicrob Resist Infect Control (2014) 0.80
Social and cultural construction of obesity among Pakistani Muslim women in North West England. Public Health Nutr (2011) 0.80
Serum galactomannan in cystic fibrosis patients colonized with Aspergillus species. Med Mycol (2012) 0.79
Factors influencing the acquisition of Stenotrophomonas maltophilia infection in cystic fibrosis patients. J Cyst Fibros (2013) 0.78
A new twist on an old problem. A case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19 A. Pediatr Infect Dis J (2009) 0.78
Acute neurological events associated with influenza vaccination: are the WHO criteria for assessing causality adequate? Scand J Infect Dis (2008) 0.78
Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel. Bioorg Med Chem Lett (2011) 0.78
How long does it take to initiate a child on long-term invasive ventilation? Results from a Canadian pediatric home ventilation program. Can Respir J (2015) 0.77
Right pneumonectomy syndrome presenting as a cardiac arrest in a two-year-old. Pediatr Crit Care Med (2009) 0.77
Narrow-spectrum cephalosporin susceptibility testing of Escherichia coli with the BD Phoenix automated system: questionable utility of cephalothin as a predictor of cephalexin susceptibility. J Clin Microbiol (2007) 0.77
Dose derivation of once-daily dosing guidelines for gentamicin in critically ill pediatric patients. Ther Drug Monit (2014) 0.77
Predictors of pandemic influenza infection in adults presenting to two urban emergency departments, Toronto, 2009. CJEM (2011) 0.77
Natural history of pandemic H1N1 2009 influenza infection in healthy pediatric outpatients. Acad Pediatr (2011) 0.77
Where should automated blood pressure measurements be taken? Pilot RCT of BpTRU measurements taken in private or nonprivate areas of a primary care office. Blood Press Monit (2012) 0.76
Severe lung injury and lung biopsy in children post-hematopoietic stem cell transplantation: The differences between allogeneic and autologous transplantation. Pediatr Transplant (2013) 0.76
Randomized controlled trial of short-term withdrawal of i.v. immunoglobulin therapy for selected children with human immunodeficiency virus infection. Pediatr Int (2007) 0.76
Factors responsible for mother-to-child HIV transmission in Ontario, Canada, 1996-2008. Can J Public Health (2014) 0.75
Quantiferon Gold-in-tube assay for TB screening in HIV infected children: influence of quantitative values. BMC Infect Dis (2014) 0.75
Managing chronic diseases: palliative care spectrum starts early on. BMJ (2005) 0.75
Should a hospitalized child receive empiric treatment with acyclovir? Ital J Pediatr (2012) 0.75
Perfluorocarbon and accuracy of tidal volume estimation. Crit Care Med (2003) 0.75
Reply to Vanhems et al. Infect Control Hosp Epidemiol (2014) 0.75
Congenital transmission of human immunodeficiency virus, cytomegalovirus, and toxoplasmosis in a premature infant. Pediatr Infect Dis J (2009) 0.75
Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU. Eur J Nucl Med Mol Imaging (2002) 0.75
Nevirapine Pharmacokinetics and Safety in Neonates Receiving Combination Antiretroviral Therapy for Prevention of Vertical HIV Transmission. J Acquir Immune Defic Syndr (2017) 0.75
Effect of a sustained inflation on regional distribution of gas and perfluorocarbon during partial liquid ventilation. Pediatr Pulmonol (2007) 0.75
Family matters: a twelve-year-old male with respiratory symptoms, cachexia and clubbing. J Paediatr Child Health (2006) 0.75
Neuroimaging findings in isoniazid central nervous system toxicity, presumed intramyelinic edema. Eur J Paediatr Neurol (2008) 0.75
SARS-CoV-2 Associated Respiratory Failure in a Preterm Infant and the Outcome after Remdesivir Treatment. Pediatr Infect Dis J (2022) 0.75
Mycobacterium Fortuitum Bloodstream Infection in a Very Low Birth Weight Preterm Neonate. Pediatr Infect Dis J (2017) 0.75
The potential impact of SARS on organ transplantation: exercise caution. Pediatr Transplant (2003) 0.75